Cyclo Therapeutics, Inc.
NASDAQ:CYTH
0.7164 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1.076 | 1.376 | 1.586 | 0.903 | 1.007 | 1.011 | 1.238 | 1.503 | 0.95 | 1.567 | 1.693 | 1.045 | 1.032 | 0.802 | 0.624 | 0.495 | 0.751 | 0.542 | 0.454 | 0.465 | 0.395 | 0.522 | 0.289 | 0.385 |
| Cost of Revenue
| 3.487 | 0.139 | 0.156 | 0.066 | 0.075 | 0.105 | 0.133 | 0.198 | 0.124 | 0.273 | 0.426 | 0.14 | 0.274 | 0.115 | 0.111 | 0.099 | 0.118 | 0.125 | 0.067 | 0.079 | 0.045 | 0.084 | 0.034 | 0.099 |
| Gross Profit
| -2.41 | 1.237 | 1.43 | 0.837 | 0.932 | 0.906 | 1.105 | 1.304 | 0.826 | 1.295 | 1.267 | 0.905 | 0.758 | 0.688 | 0.513 | 0.396 | 0.633 | 0.417 | 0.388 | 0.386 | 0.349 | 0.438 | 0.255 | 0.285 |
| Gross Profit Ratio
| -2.239 | 0.899 | 0.902 | 0.927 | 0.925 | 0.896 | 0.893 | 0.868 | 0.869 | 0.826 | 0.748 | 0.866 | 0.735 | 0.857 | 0.822 | 0.799 | 0.842 | 0.769 | 0.853 | 0.83 | 0.885 | 0.838 | 0.882 | 0.742 |
| Reseach & Development Expenses
| 14.182 | 9 | 9.154 | 6.096 | 4.869 | 2.711 | 2.293 | 1.865 | 0.659 | 0.094 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 5.662 | 7.805 | 6.498 | 3.676 | 3.433 | 2.43 | 2.625 | 2.644 | 2.223 | 1.535 | 0.64 | 0.56 | 0.8 | 0.679 | 0.693 | 0.52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0.004 | 0.013 | 0.018 | 0.005 | 0.006 | 0.006 | 0.008 | 0.007 | 0.008 | 0.011 | 0.009 | 0.011 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 3.458 | 7.818 | 6.516 | 3.681 | 3.439 | 2.436 | 2.633 | 2.651 | 2.231 | 1.545 | 0.648 | 0.571 | 0.8 | 0.679 | 0.693 | 0.52 | 0.439 | 0.351 | 0.5 | 0.665 | 0.263 | 0.241 | 0.279 | 0.549 |
| Other Expenses
| 1.194 | 0.031 | 0.028 | 0.02 | 0.014 | 0.014 | 0.02 | 0.131 | 0.202 | 0.218 | 0.189 | 0.16 | 0.033 | 0.021 | 0.021 | 0.023 | 0.439 | 0.351 | 0.5 | 0.665 | 0.263 | 0.241 | 0.279 | 0.575 |
| Operating Expenses
| 17.64 | 16.848 | 15.698 | 9.797 | 8.322 | 5.161 | 4.945 | 4.647 | 3.091 | 1.857 | 0.837 | 0.731 | 0.832 | 0.7 | 0.714 | 0.543 | 0.439 | 0.351 | 0.5 | 0.665 | 0.263 | 0.241 | 0.279 | 0.575 |
| Operating Income
| -20.05 | -15.612 | -14.268 | -8.96 | -7.391 | -4.267 | -3.843 | -4.206 | -2.407 | -0.562 | 0.337 | 0.157 | -0.074 | -0.012 | -0.201 | -0.239 | 0.194 | -0.046 | -0.113 | -0.279 | 0.086 | 0.197 | -0.024 | -0.29 |
| Operating Income Ratio
| -18.627 | -11.348 | -8.998 | -9.918 | -7.338 | -4.218 | -3.105 | -2.798 | -2.532 | -0.359 | 0.199 | 0.151 | -0.072 | -0.015 | -0.322 | -0.484 | 0.258 | -0.085 | -0.248 | -0.6 | 0.217 | 0.378 | -0.082 | -0.754 |
| Total Other Income Expenses Net
| -0.007 | 0.161 | -0.019 | 0.019 | -0.142 | -0 | 0.008 | -0.853 | -0.135 | 0.003 | -0.091 | -0.013 | 0.002 | 0.004 | 0.008 | -0.064 | 0.021 | -0.157 | 0.179 | -0.271 | 0.007 | -0.001 | 0.003 | 0.002 |
| Income Before Tax
| -20.057 | -15.451 | -14.287 | -8.942 | -7.533 | -4.255 | -3.833 | -4.224 | -2.431 | -0.593 | 0.285 | 0.099 | -0.098 | -0.013 | -0.193 | -0.213 | 0.204 | -0.102 | 0.053 | -0.561 | 0.07 | 0.166 | -0.057 | -0.316 |
| Income Before Tax Ratio
| -18.634 | -11.231 | -9.009 | -9.898 | -7.479 | -4.207 | -3.097 | -2.81 | -2.558 | -0.378 | 0.168 | 0.095 | -0.095 | -0.016 | -0.31 | -0.431 | 0.271 | -0.188 | 0.116 | -1.208 | 0.177 | 0.317 | -0.195 | -0.821 |
| Income Tax Expense
| 0 | -0.171 | 0.019 | -0.019 | 0.142 | 0.012 | 0 | 0.029 | 0.12 | 0.034 | 0.08 | 0.025 | 0.026 | 0.025 | 0 | 0.2 | -0.45 | 0.168 | 0.225 | 0.283 | -0.225 | 0.032 | 0.09 | 0.195 |
| Net Income
| -20.057 | -15.28 | -14.305 | -8.923 | -7.674 | -4.255 | -3.833 | -4.224 | -2.551 | -0.593 | 0.205 | 0.074 | -0.098 | -0.038 | -0.193 | -0.413 | 0.654 | -0.102 | -0.172 | -0.561 | 0.295 | 0.166 | -0.114 | -0.511 |
| Net Income Ratio
| -18.634 | -11.107 | -9.021 | -9.877 | -7.619 | -4.207 | -3.097 | -2.81 | -2.684 | -0.378 | 0.121 | 0.071 | -0.095 | -0.047 | -0.31 | -0.835 | 0.87 | -0.188 | -0.38 | -1.208 | 0.748 | 0.317 | -0.393 | -1.328 |
| EPS
| -1.23 | -1.81 | -2.25 | -5.58 | -7.09 | -5.2 | -5.32 | -6.67 | -4.54 | -1.17 | 1 | 1 | -0.27 | -0.11 | -0.67 | -1.76 | 3.6 | -0.69 | -1.44 | -7.76 | 5 | 3 | -2.59 | -13.8 |
| EPS Diluted
| -1.23 | -1.81 | -2.25 | -5.58 | -7.09 | -5.2 | -5.32 | -6.67 | -4.54 | -1.17 | 1 | 1 | -0.27 | -0.11 | -0.67 | -1.76 | 3.6 | -0.69 | -1.44 | -7.76 | 5 | 3 | -2.59 | -13.8 |
| EBITDA
| -20.031 | -15.753 | -14.233 | -8.966 | -7.243 | -4.244 | -3.831 | -3.235 | -2.096 | -0.41 | 0.578 | 0.317 | -0.042 | 0.009 | -0.18 | -0.124 | 0.197 | 0.251 | -0.257 | 0.019 | 0.116 | 0.222 | 0.025 | -0.266 |
| EBITDA Ratio
| -18.609 | -11.45 | -8.975 | -9.925 | -7.192 | -4.196 | -3.095 | -2.153 | -2.206 | -0.261 | 0.341 | 0.303 | -0.04 | 0.011 | -0.289 | -0.251 | 0.263 | 0.463 | -0.565 | 0.042 | 0.295 | 0.426 | 0.086 | -0.691 |